JPH0746992A - Production of hyaluronic acid - Google Patents

Production of hyaluronic acid

Info

Publication number
JPH0746992A
JPH0746992A JP19592493A JP19592493A JPH0746992A JP H0746992 A JPH0746992 A JP H0746992A JP 19592493 A JP19592493 A JP 19592493A JP 19592493 A JP19592493 A JP 19592493A JP H0746992 A JPH0746992 A JP H0746992A
Authority
JP
Japan
Prior art keywords
hyaluronic acid
streptococcus
arginine
amino acids
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19592493A
Other languages
Japanese (ja)
Inventor
Masamichi Hashimoto
正道 橋本
Susumu Chiba
晋 千葉
Kazuaki Maeda
和章 前田
Teruzo Miyoshi
照三 三好
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denki Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denki Kagaku Kogyo KK filed Critical Denki Kagaku Kogyo KK
Priority to JP19592493A priority Critical patent/JPH0746992A/en
Publication of JPH0746992A publication Critical patent/JPH0746992A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE:To obtain in high yield hyaluronic acid useful for medicines, etc., easy to isolate and purify, by culturing microbes capable of producing hyaluronic acid in a culture fluid in the presence of amino acids such as arginine without being affected by the variation in the components in natural nutrients. CONSTITUTION:The objective compound, hyaluronic acid, can be obtained by culturing, under aerobic conditions, microbes capable of producing hyaluronic acid, a kind selected from Streptococcus equi and respective mutants thereof FM-100 (FERM P-9027) and FM-300 (FERM P-2319), in a culture fluid incorporated with 8 kinds of amino acids, i.e., arginine, glutamine, serine, glycine, methionine, leucine, isoleucine and lysine.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、発酵法による医薬用ヒ
アルロン酸の製造方法に関する。更に詳しくは、アルギ
ニン、グルタミン、セリン、グリシン、メチオニン、イ
ソロイシン、ロイシン及びリジンの8種のアミノ酸を添
加した培養液中でヒアルロン酸産生能を有する微生物を
培養して、発酵法により医薬用ヒアルロン酸を得る方法
に関する。
FIELD OF THE INVENTION The present invention relates to a method for producing medicinal hyaluronic acid by a fermentation method. More specifically, a microorganism capable of producing hyaluronic acid is cultured in a culture medium containing eight kinds of amino acids of arginine, glutamine, serine, glycine, methionine, isoleucine, leucine and lysine, and the medicinal hyaluronic acid is fermented by a fermentation method. Regarding how to get.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】従来、
ヒアルロン酸はニワトリのトサカ、牛の眼の硝子体等よ
り抽出によって得られていた。しかしながら抽出法によ
る生体よりのヒアルロン酸製造は多量のヒアルロン酸と
類似のムコ多糖類とか蛋白質等の多量の夾雑物との分
離、及び組織内に含まれるヒアルロニダーゼなどによっ
て低分子化を生じるなど分離、精製が非常に繁雑等の問
題点を有していた。その問題点を改良するために、ヒア
ルロン酸産生能を有する微生物であるストレプトコッカ
ス属の微生物を培養して、その培養液からヒアルロン酸
を分離、精製する方法が開示されている。(特公平4-12
960 号) さらに、ヒアルロン酸生産性の安定化及び生産収率を向
上させるため、変異株を利用する方法(特公平4-43637
号、特公平4-55675 号)、培養条件を制御する方法(特
開平3-35788 号、特公平4-64679 号)、有効成分を添加
する方法(特開昭62-289198 号、特開平4-18839 号)等
が開示されている。
2. Description of the Related Art Conventionally, the problems to be solved by the invention
Hyaluronic acid was obtained by extraction from the chicken of the chicken, the vitreous of the eye of the cow, and the like. However, the production of hyaluronic acid from the living body by the extraction method separates a large amount of hyaluronic acid from similar mucopolysaccharides and a large amount of contaminants such as proteins, and lowers the molecular weight due to hyaluronidase contained in tissues, etc. There was a problem that the purification was very complicated. In order to improve the problem, a method of culturing a microorganism of the genus Streptococcus, which is a microorganism capable of producing hyaluronic acid, and separating and purifying hyaluronic acid from the culture solution is disclosed. (Patent Fair 4-12
No. 960) Furthermore, in order to stabilize the hyaluronic acid productivity and improve the production yield, a method using a mutant strain (Japanese Patent Publication No. 4-43637).
Japanese Patent Publication No. 4-55675), a method of controlling culture conditions (Japanese Patent Laid-Open No. 3-35788, Japanese Patent Publication No. 4-64679), and a method of adding an active ingredient (Japanese Patent Laid-Open No. 62-289198, Japanese Patent Laid-Open No. 4-198198). -18839) is disclosed.

【0003】しかし、いずれの方法もヒアルロン酸生産
能を有する微生物の持つ性質である栄養要求性の複雑さ
のため、栄養が豊富でしかも微生物の増殖に対し阻害性
の少ない天然有機栄養源混合物、例えば酵母エキスやポ
リペプトンなどを多量に培地に添加する必要があった。
However, in any of these methods, due to the complexity of the auxotrophy, which is a property of a microorganism capable of producing hyaluronic acid, a mixture of natural organic nutrient sources rich in nutrients and less inhibitory to the growth of microorganisms, For example, it was necessary to add a large amount of yeast extract or polypeptone to the medium.

【0004】ところが、従来の培養法で用いられている
天然有機栄養源混合物は糖、蛋白、アミノ酸、脂質、核
酸、ビタミン、金属など様々な成分を含んでおり、これ
らの中にはヒアルロン酸生産に必要な成分を含んでいる
反面、不必要な成分も数多く含まれている。特に医薬用
ヒアルロン酸の精製工程はこれら不要成分の除去も考慮
する必要があり、ヒアルロン酸の性質に起因する難しさ
に加え、工程が繁雑化し、その結果、分子量などの品質
の維持と工程の簡略化がより困難となってくる。精製工
程の負荷は天然有機栄養源混合物の添加量を少なくする
ことで軽減可能であるが、反面ヒアルロン酸生産に必要
な成分も減少するためにヒアルロン酸の収率が低下する
などの課題があった。
However, the natural organic nutrient mixture used in the conventional culture method contains various components such as sugars, proteins, amino acids, lipids, nucleic acids, vitamins and metals, among which hyaluronic acid is produced. On the other hand, it contains a lot of unnecessary ingredients. In particular, it is necessary to consider the removal of these unnecessary components in the purification step of hyaluronic acid for pharmaceuticals, and in addition to the difficulty due to the property of hyaluronic acid, the step becomes complicated, and as a result, maintenance of quality such as molecular weight and process Simplification becomes more difficult. Although the burden of the purification process can be reduced by reducing the amount of the natural organic nutrient mixture added, on the other hand, there are problems such as a decrease in the yield of hyaluronic acid due to a decrease in the components required for hyaluronic acid production. It was

【0005】本発明者らは、かかる課題を解決すべく鋭
意検討を行った結果、アルギニン、グルタミン、メチ
オニン、セリン、グリシン、イソロイシン、ロイシン及
びリジンの8種類のアミノ酸を添加することで、ヒアル
ロン酸の収量を低下させずに天然有機栄養源混合物の添
加量を減らすことができる、天然栄養源中の成分のば
らつきに影響されずに安定にヒアルロン酸を生成するこ
とができる、ヒアルロン酸の分離、精製工程の負荷を
軽減できる等を見いだし本発明を完成するに至った。
As a result of intensive studies to solve the above problems, the present inventors have found that hyaluronic acid is added by adding eight kinds of amino acids, arginine, glutamine, methionine, serine, glycine, isoleucine, leucine and lysine. The amount of natural organic nutrient mixture added can be reduced without lowering the yield, the hyaluronic acid can be stably produced without being affected by the variation of the components in the natural nutrient source, the separation of hyaluronic acid, The inventors have found that the load of the refining process can be reduced, and completed the present invention.

【0006】[0006]

【課題を解決するための手段】すなわち、本発明は、
(1)ヒアルロン酸産生能を有する微生物を、培養液中
にアルギニン、グルタミン、セリン、グリシン、メチオ
ニン、イソロイシン、ロイシン及びリジンの8種のアミ
ノ酸を添加して培養することを特徴とする発酵法による
ヒアルロン酸の製造方法、(2)ヒアルロン酸産生能を
有する微生物がストレプトコッカス属細菌である(1)
記載のヒアルロン酸の製造方法、(3)ストレプトコッ
カス属細菌がストレプトコッカス・エキ、ストレプトコ
ッカス・エキの変異株FM−100(微工研条寄第90
27号)及びストレプトコッカス・エキの変異株FM−
300(微工研条寄第2319号)から選ばれた1種で
ある(2)記載のヒアルロン酸の製造方法である。
That is, the present invention is
(1) By a fermentation method, which comprises culturing a microorganism capable of producing hyaluronic acid by adding 8 kinds of amino acids of arginine, glutamine, serine, glycine, methionine, isoleucine, leucine and lysine to a culture solution Method for producing hyaluronic acid, (2) Microorganism capable of producing hyaluronic acid is a bacterium of the genus Streptococcus (1)
The method for producing hyaluronic acid according to (3), wherein the bacterium belonging to the genus Streptococcus is Streptococcus equi, a mutant strain FM-100 of Streptococcus equi (Microtechnology Research Institute Article 90
27) and a mutant strain FM- of Streptococcus equi
The method for producing hyaluronic acid according to (2), which is one kind selected from 300 (Microtechnical Laboratory Article No. 2319).

【0007】以下、本発明について具体的に説明する。
本発明に用いられるヒアルロン酸産生能を有する微生物
としては、ストレプトコッカス・エキ(Streptococcus
equi) 、ストレプトコッカス・ズーエピデミカス(Strep
tococcus zooepidemicus) 、ストレプトコッカス・エキ
シミリス(Streptococcus equisimilis) 、ストレプトコ
ッカス・デイガラクテイエ(Streptococcusdysgalactia
e)、ストレプトコッカス・ピオゲネス(Streptococcus p
yogenes)およびこれらの変異株などが挙げられるが、な
かでもストレプトコッカス・エキが好ましく、特にスト
レプトコッカス・エキの変異株FM−100(微工研条
寄第9027号)又はストレプトコッカス・エキの変異
株FM−300(微工研条寄第2319号)が好まし
い。
The present invention will be specifically described below.
Examples of the microorganism capable of producing hyaluronic acid used in the present invention include Streptococcus
equi), Streptococcus zooepidemicus (Strep
tococcus zooepidemicus), Streptococcus equisimilis, Streptococcus deygalactiae (Streptococcus dysgalactia)
e), Streptococcus p.
yogenes) and these mutants, among others, Streptococcus equi is preferable, and particularly Streptococcus equi mutant strain FM-100 (Mikokukenjojo 9027) or Streptococcus equi mutant strain FM-. 300 (Ministry of Industrial Science and Technology No. 2319) is preferable.

【0008】本発明に用いる培地はグルコース、フラク
トース、ガラクトース、シュークロース等の糖成分から
なる炭素源、リン酸第1カリウム、リン酸第2カリウ
ム、硝酸マグネシウム、亜硫酸ナトリウム、チオ硫酸ナ
トリウム、リン酸アンモニウム等の無機塩類、ポリペプ
トン、カザミノ酸、酵母エキス、コーンスティープリカ
ー、大豆加水分解液等の有機栄養源、他必要に応じて各
種ビタミン類等が好適に用いられる。この際、適量のア
ルギニン、グルタミン、メチオニン、セリン、グリシ
ン、イソロイシン、ロイシン及びリジンの8種類のアミ
ノ酸を添加する。添加量に制限はないが、過量添加では
一定以上の効果はみられないので好ましくは糖成分1%
当り各々0. 001〜0. 1%、更に好ましくは0. 0
01〜0. 05%添加すればよい。これらのアミノ酸を
添加することにより、従来用いられていた培地の有機栄
養源量を大幅に減らすことが可能となり、収量を低下さ
せることなく精製工程の負担を軽減することができる。
The medium used in the present invention is a carbon source consisting of sugar components such as glucose, fructose, galactose, sucrose, etc., primary potassium phosphate, secondary potassium phosphate, magnesium nitrate, sodium sulfite, sodium thiosulfate, and phosphoric acid. Inorganic salts such as ammonium, polypeptone, casamino acid, yeast extract, corn steep liquor, organic nutrient sources such as soybean hydrolyzate, and various vitamins and the like are preferably used if necessary. At this time, an appropriate amount of eight kinds of amino acids of arginine, glutamine, methionine, serine, glycine, isoleucine, leucine and lysine are added. There is no limit to the amount added, but it is preferable that the sugar component is 1%, since the effect above a certain level is not seen if added in excess.
0.001 to 0.1% each, more preferably 0.0
It is sufficient to add 01 to 0.05%. By adding these amino acids, it becomes possible to significantly reduce the amount of organic nutrient source in the medium that has been conventionally used, and it is possible to reduce the burden of the purification process without lowering the yield.

【0009】本発明の培養は通気後撹拌培養等の公知の
方法でよく、培養温度は30〜35℃が好ましい。培養
液のpHは菌の生育と共に低下するため水酸化ナトリウ
ム、水酸化カリウム、アンモニア等のpH調整剤を添加
しpH6. 0〜9. 0にコントロールする。このように
して培養すると、ヒアルロン酸の生成と共に培養液の粘
度が次第に上昇してくる。使用炭素源が培養液中で消費
された時点で培養を停止し、活性炭処理、ろ過による除
菌後アルコール等の有機溶剤による析出、限外濾過によ
る脱塩等の簡単な公知精製法により高純度ヒアルロン酸
が得られる。
The culture of the present invention may be carried out by a known method such as stirring culture after aeration, and the culture temperature is preferably 30 to 35 ° C. Since the pH of the culture solution decreases with the growth of the bacterium, a pH adjusting agent such as sodium hydroxide, potassium hydroxide or ammonia is added to control the pH to 6.0 to 9.0. When culturing is performed in this manner, the viscosity of the culture solution gradually increases with the production of hyaluronic acid. Cultivation is stopped when the used carbon source is consumed in the culture solution, and high purity is achieved by a simple known purification method such as activated carbon treatment, sterilization by filtration, precipitation with an organic solvent such as alcohol, and desalting by ultrafiltration. Hyaluronic acid is obtained.

【0010】天然有機栄養源混合物に多量に含まれる成
分としてヒアルロン酸生産に必須であるアミノ酸に着目
し、ストレプトコッカス・エキを培養し、培養液中濃度
の消長とヒアルロン酸生産量の関係について詳細に検討
した。培養中のアミノ酸濃度を経時的に定量したとこ
ろ、グルタミン、アルギニン、セリン、グリシン、メチ
オニン、イソロイシン、ロイシン、リジンは消費され、
バリン、ヒスチジンなどはほとんど変化が無く、そし
て、アスパラギンに加え、ストレプトコッカス・エキNK
-850215 にはヒアルロン酸生産に有効とされていたグル
タミン酸(特開昭626-289198号)などは逆に蓄積されて
いた。結果を表1に示す。
Focusing on amino acids that are essential for hyaluronic acid production as a component contained in a large amount in a mixture of natural organic nutrients, Streptococcus equi was cultivated, and the relationship between the change in concentration in the culture solution and the amount of hyaluronic acid produced was detailed. investigated. When the amino acid concentration in the culture was quantified over time, glutamine, arginine, serine, glycine, methionine, isoleucine, leucine, and lysine were consumed,
Valine, histidine, etc. are almost unchanged, and in addition to asparagine, Streptococcus eki NK
Glutamic acid (Japanese Patent Laid-Open No. 626-289198), which was said to be effective for hyaluronic acid production, was accumulated in -850215. The results are shown in Table 1.

【0011】[0011]

【表1】 [Table 1]

【0012】さらに、この中で消費されるアミノ酸につ
いて更に詳細に検討した。一般に培養における菌体増殖
は誘導期、対数増殖期、静止期、死滅期に分けることが
できる。各々の時期ごとにアミノ酸の比消費速度(菌体
当りの消費速度)及びヒアルロン酸の比生産速度(菌体
当りの生産速度)を算出したところ、ヒアルロン酸の比
生産速度の大きい、すなわちヒアルロン酸生産が最も盛
んな静止期において、ストレプトコッカス・エキNK-850
215 にはヒアルロン酸生産に有効とされていたアルギニ
ン(特開昭62-289198 号)、グループAに属するストレ
プトコッカスに有効とされていたグルタミン(D.S.WILL
OUGHBY etal.,1964.J.Bacteriol.87.1452-1456) の2種
類のアミノ酸の他に、さらに、セリン、グリシン、メチ
オニン、イソロイシン、ロイシン及びリジンの6種類の
アミノ酸の比消費速度もそれに対応し非常に大きい事よ
り、これら8種類のアミノ酸がヒアルロン酸生産に必須
であることを見いだした。
[0012] Further, the amino acids consumed therein were examined in more detail. Generally, bacterial cell growth in culture can be divided into an induction phase, a logarithmic growth phase, a stationary phase, and a death phase. When the specific consumption rate of amino acids (consumption rate per cell) and the specific production rate of hyaluronic acid (production rate per cell) were calculated for each period, the specific production rate of hyaluronic acid was high, that is, hyaluronic acid. Streptococcus equi NK-850 during the stationary phase when production is most active
In 215, arginine (JP-A-62-289198), which was said to be effective for hyaluronic acid production, and glutamine (DSWILL, which was effective for streptococcus belonging to Group A) were used.
OUGHBY et al., 1964. J. Bacteriol. 87.1452-1456), and the specific consumption rate of 6 kinds of amino acids, serine, glycine, methionine, isoleucine, leucine and lysine, is also very high. It was found that these eight kinds of amino acids are essential for hyaluronic acid production.

【0013】次に、天然有機栄養源混合物に含まれる成
分の中で微量ながらヒアルロン酸生産に必須であるもの
について、天然有機栄養源の最小必要量として詳細に検
討した。アルギニン、グルタミン、セリン、グリシン、
メチオニン、イソロイシン、ロイシン及びリジンの8種
類のアミノ酸は十分量添加し、天然有機栄養源としての
酵母エキス及びポリペプトンは段階的の濃度となるよう
に調整し、その培養液から得られるヒアルロン酸の収量
を比較した。ヒアルロン酸の収量は天然有機栄養源とし
て酵母エキスが0. 17%、ポリペプトンが0. 5%以
上でおよそ7.5g/lと変わらなかった。しかし、そ
れより低い濃度では微量な金属やビタミンの影響と考え
られる制限によりヒアルロン酸収量は低下した。酵母エ
キス及びポリペプトン濃度と収量の関係の結果を表2に
示す。
Next, among the components contained in the mixture of natural organic nutrients, those that are essential for the production of hyaluronic acid, although they are trace amounts, were examined in detail as the minimum required amount of natural organic nutrients. Arginine, glutamine, serine, glycine,
Eight kinds of amino acids of methionine, isoleucine, leucine and lysine were added in sufficient amounts, and yeast extract and polypeptone as natural organic nutrient sources were adjusted to have gradual concentrations, and the yield of hyaluronic acid obtained from the culture solution was adjusted. Were compared. The yield of hyaluronic acid was about 7.5 g / l, which was 0.17% for yeast extract and 0.5% or more for polypeptone as natural organic nutrient sources. However, at lower concentrations, the hyaluronic acid yield decreased due to the restriction of trace metals and vitamins. The results of the relationship between the yeast extract and polypeptone concentration and the yield are shown in Table 2.

【0014】[0014]

【表2】 [Table 2]

【0015】さらに、アルギニン、グルタミン、セリ
ン、グリシン、メチオニン、イソロイシン、ロイシン及
びリジンの8種類のいずれか1つのアミノ酸が不足して
もヒアルロン酸収量がおよそ7.5g/lから4.5g
/lまで低下することがわかり、従来、ヒアルロン酸生
産に有効であるとされているアルギニンやグルタミン単
独では収量の維持は出来なかった。
Furthermore, even if any one of the eight amino acids of arginine, glutamine, serine, glycine, methionine, isoleucine, leucine and lysine is deficient, the yield of hyaluronic acid is about 7.5 g / l to 4.5 g.
It was found that the amount decreased to 1 / l, and the yield could not be maintained with arginine and glutamine alone, which were conventionally considered to be effective for hyaluronic acid production.

【0016】次に精製工程の負荷について天然有機栄養
源に由来する培養液の着色度に着目して詳細に検討し
た。培地の着色は主に天然有機栄養源、例えばポリペプ
トンや酵母エキスに由来し、その量は直接に精製工程の
負荷につながる。(A)天然有機栄養源として酵母エキ
ス0. 17%、ポリペプトン0. 5%、そして、アルギ
ニン、グルタミン、セリン、グリシン、メチオニン、イ
ソロイシン、ロイシン及びリジンの8種類のアミノ酸を
加えた培地と(B)酵母エキス0. 5%、ポリペプトン
1. 5%を含む培地を例として培養液の着色度を比較し
た。それぞれの培地で培養した培養液を塩酸でpH4に
調整後、活性炭処理し、ろ過により除菌して着色度を5
50nmの吸光度より求めたところ、(A)の培地は
0.000と無色透明であり、(B)の培地は0.03
5であった。吸光度がおよそ1/3まで低下したことよ
り精製工程の負荷を大幅に軽減できることが示された。
Next, the purification process load was examined in detail by focusing on the degree of coloring of the culture broth derived from a natural organic nutrient source. The coloring of the medium is mainly derived from natural organic nutrient sources such as polypeptone and yeast extract, and the amount thereof directly imposes a burden on the purification process. (A) A medium containing 0.17% yeast extract, 0.5% polypeptone as a natural organic nutrient source, and eight kinds of amino acids of arginine, glutamine, serine, glycine, methionine, isoleucine, leucine and lysine (B) ) The degree of coloring of the culture solutions was compared using a medium containing yeast extract 0.5% and polypeptone 1.5% as an example. After adjusting the pH of the culture broth that was cultivated in each medium to 4 with hydrochloric acid, it was treated with activated charcoal and sterilized by filtration to give a coloring degree of 5
When calculated from the absorbance at 50 nm, the medium (A) was 0.000 and was colorless and transparent, and the medium (B) was 0.03.
It was 5. Since the absorbance was reduced to about 1/3, it was shown that the load on the purification step could be significantly reduced.

【0017】[0017]

【実施例】以下、本発明を実施例により、更に具体的に
説明するが、本発明はこれらに限定されない。
EXAMPLES The present invention will now be described in more detail by way of examples, but the present invention is not limited thereto.

【0018】実施例1 グルコース5%、リン酸第2カリウム0. 2%、ポリペ
プトン0. 5%、酵母エキス0. 17%、アルギニン
0. 2%、グルタミン0. 2%、メチオニン0.05
%、セリン0. 05%、グリシン0. 05%、イソロイ
シン0. 05%、ロイシン0. 05%、リジン0. 01
%からなる培地に前培養したストレプトコッカス・エキ
FM−100(微工研条寄第9027号)を接種し、
通気量1vvm、撹拌200回転/分、温度33℃で水
酸化ナトリウムでpHを8. 5にコントロールしながら
培養した。終了時点での培養時間は14時間であった。
培養液を塩酸でpH4に調整後、蒸留水で2倍希釈し、
活性炭処理、ろ過により除菌した。得られた除菌液にエ
チルアルコールを加え、ヒアルロン酸ナトリウムを析出
せしめる。これをろ別した後、水に溶解し、セチルピリ
ジニウムクロライドを加え、生じた沈澱をろ取し、2%
食塩水に再溶解後、再びエチルアルコールによる析出を
繰り返す。得られたヒアルロン酸ナトリウムを室温で減
圧乾燥して、培養液1L当たり白色のヒアルロン酸ナト
リウム7. 5gを得た。対糖収率は15. 0%であっ
た。また、培養液を塩酸でpH4に調整後、活性炭処理
を行なった時点に於ける550nmの吸光度は0.00
0で無色であった。結果を表3に示す。
Example 1 Glucose 5%, dibasic potassium phosphate 0.2%, polypeptone 0.5%, yeast extract 0.17%, arginine 0.2%, glutamine 0.2%, methionine 0.05.
%, Serine 0.05%, glycine 0.05%, isoleucine 0.05%, leucine 0.05%, lysine 0.01%
% Inoculated with a pre-cultured Streptococcus eki FM-100 (Mikoken Kenjoyori No. 9027),
The culture was carried out at aeration of 1 vvm, agitation of 200 revolutions / minute, and a temperature of 33 ° C. while controlling the pH to 8.5 with sodium hydroxide. The culture time at the end was 14 hours.
After adjusting the pH of the culture solution to 4 with hydrochloric acid, dilute it twice with distilled water.
The bacteria were removed by treatment with activated carbon and filtration. Ethyl alcohol is added to the obtained sterilized solution to precipitate sodium hyaluronate. After this was filtered off, it was dissolved in water, cetylpyridinium chloride was added, and the resulting precipitate was collected by filtration and 2%
After redissolving in saline, precipitation with ethyl alcohol is repeated again. The obtained sodium hyaluronate was dried under reduced pressure at room temperature to obtain 7.5 g of white sodium hyaluronate per 1 L of the culture solution. The yield based on sugar was 15.0%. Further, after the pH of the culture solution was adjusted to 4 with hydrochloric acid, the absorbance at 550 nm at the time of treatment with activated carbon was 0.00
It was 0 and was colorless. The results are shown in Table 3.

【0019】実施例2 ヒアルロン酸産生能を有する微生物として、ストレプト
コッカス・エキ FM−300(微工研条寄第2319
号)を用いる以外は、実施例1と同様の条件で実施し
た。結果を表3に示す。
Example 2 As a microorganism having a hyaluronic acid-producing ability, Streptococcus equi FM-300 (Microtechnical Lab.
No.) was used and the conditions were the same as in Example 1. The results are shown in Table 3.

【0020】比較例1〜8 グルコース5%、リン酸第2カリウム0. 2%、ポリペ
プトン0. 5%、酵母エキス0. 17%、アルギニン
0. 2%、グルタミン0. 2%、メチオニン0.05
%、セリン0. 05%、グリシン0. 05%、イソロイ
シン0. 05%、ロイシン0. 05%、リジン0. 05
%からなる培地よりアルギニン、グルタミン、メチオニ
ン、セリン、グリシン、イソロイシン、ロイシン、リジ
ンの1つを欠いた培地に前培養したストレプトコッカス
・エキ FM−100(微工研条寄第9027号)を接
種し、培養した。培養終了後は実施例と同様な方法で精
製し、結果は表3に示した通り、各アミノ酸を1種でも
欠いた培地では収量が劣っていた。
Comparative Examples 1-8 Glucose 5%, dibasic potassium phosphate 0.2%, polypeptone 0.5%, yeast extract 0.17%, arginine 0.2%, glutamine 0.2%, methionine 0.2. 05
%, Serine 0.05%, glycine 0.05%, isoleucine 0.05%, leucine 0.05%, lysine 0.05%
% Of arginine, glutamine, methionine, serine, glycine, isoleucine, leucine, and lysine inoculated with pre-cultured Streptococcus eki FM-100 (Microtechnical Research Institute No. 9027). , Cultured. After the completion of the culture, the product was purified in the same manner as in Example. As shown in Table 3, the yield was poor in the medium lacking even one kind of each amino acid.

【0021】比較例9 グルコース5%、リン酸第2カリウム0. 2%、ポリペ
プトン1. 5%、酵母エキス0. 5%、からなる培地に
前培養したストレプトコッカス・エキ FM−100
(微工研条寄第9027号)を接種し、通気量1vv
m、撹拌200回転/分、温度33℃で苛性ソーダでp
Hを8. 5にコントロールしながら培養した。終了時点
での培養時間は14時間であった。培養液を塩酸でpH
4に調整後、実施例1と同様な活性炭処理を行ない55
0nmにおける吸光度を測定した。吸光度は0.035
で着色していた。結果を表3に示す。
Comparative Example 9 Streptococcus equi FM-100 pre-cultured in a medium consisting of 5% glucose, 0.2% dibasic potassium phosphate, 1.5% polypeptone, 0.5% yeast extract.
Inoculated with (Microtechnology Research Institute No. 9027), aeration of 1vv
m, stirring 200 rev / min, temperature 33 ° C with caustic soda
The culture was performed while controlling H to 8.5. The culture time at the end was 14 hours. PH of the culture solution with hydrochloric acid
After adjusting to 4, the same activated carbon treatment as in Example 1 was carried out 55
The absorbance at 0 nm was measured. Absorbance is 0.035
It was colored with. The results are shown in Table 3.

【0022】[0022]

【表3】 [Table 3]

【0023】[0023]

【発明の効果】本発明によれば、下記のような効果があ
るのでヒアルロン酸の工業的な製造法として極めて有用
である。 アルギニン、グルタミン、メチオニン、セリン、グリ
シン、イソロイシン、ロイシン及びリジンの8つのアミ
ノ酸を適量添加することで、天然有機栄養源混合物を減
らすことができ、天然有機栄養源混合物を多量に用いた
培養方法と同様に高収量ヒアルロン酸ナトリウムを得る
ことができる。 天然有機栄養源を少なくすることでヒアルロン酸の分
離、精製工程の負荷を大幅に軽減できる。 ヒアルロン酸生産に必要な栄養源を添加することで天
然栄養源中の成分のばらつきに影響されることがなくな
り培養収量が安定化し、管理が容易にできる。
EFFECTS OF THE INVENTION According to the present invention, since it has the following effects, it is extremely useful as an industrial production method of hyaluronic acid. By adding eight amino acids of arginine, glutamine, methionine, serine, glycine, isoleucine, leucine and lysine in an appropriate amount, it is possible to reduce the natural organic nutrient mixture, and a culture method using a large amount of the natural organic nutrient mixture. Similarly, high yields of sodium hyaluronate can be obtained. By reducing the amount of natural organic nutrients, the load on the hyaluronic acid separation and purification process can be greatly reduced. By adding the nutrient source necessary for hyaluronic acid production, the culture yield is stabilized without being affected by the variation in the components in the natural nutrient source, and the management is easy.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 三好 照三 東京都町田市旭町3丁目5番1号 電気化 学工業株式会社総合研究所内 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Terumi Miyoshi 3-5-1, Asahimachi, Machida-shi, Tokyo Denka Kagaku Kogyo Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 ヒアルロン酸産生能を有する微生物を、
培養液中にアルギニン、グルタミン、セリン、グリシ
ン、メチオニン、イソロイシン、ロイシン及びリジンの
8種のアミノ酸を添加して培養することを特徴とする発
酵法によるヒアルロン酸の製造方法。
1. A microorganism capable of producing hyaluronic acid,
A method for producing hyaluronic acid by fermentation, which comprises adding 8 kinds of amino acids of arginine, glutamine, serine, glycine, methionine, isoleucine, leucine and lysine to a culture solution and culturing.
【請求項2】 ヒアルロン酸産生能を有する微生物がス
トレプトコッカス属細菌である請求項1記載のヒアルロ
ン酸の製造方法。
2. The method for producing hyaluronic acid according to claim 1, wherein the microorganism capable of producing hyaluronic acid is a bacterium belonging to the genus Streptococcus.
【請求項3】 ストレプトコッカス属細菌がストレプト
コッカス・エキ、ストレプトコッカス・エキの変異株F
M−100(微工研条寄第9027号)及びストレプト
コッカス・エキの変異株FM−300(微工研条寄第2
319号)から選ばれた1種である請求項2記載のヒア
ルロン酸の製造方法。
3. A bacterium belonging to the genus Streptococcus is Streptococcus equi, a mutant strain F of Streptococcus equi.
M-100 (Microtechnology Research Institute No. 9027) and Streptococcus equi mutant FM-300 (Microtechnology Research Laboratories No. 2)
319) and the method for producing hyaluronic acid according to claim 2.
JP19592493A 1993-08-06 1993-08-06 Production of hyaluronic acid Pending JPH0746992A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19592493A JPH0746992A (en) 1993-08-06 1993-08-06 Production of hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19592493A JPH0746992A (en) 1993-08-06 1993-08-06 Production of hyaluronic acid

Publications (1)

Publication Number Publication Date
JPH0746992A true JPH0746992A (en) 1995-02-21

Family

ID=16349250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19592493A Pending JPH0746992A (en) 1993-08-06 1993-08-06 Production of hyaluronic acid

Country Status (1)

Country Link
JP (1) JPH0746992A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010631A1 (en) 2008-07-25 2010-01-28 電気化学工業株式会社 Method for producing hyaluronic acid
JP2013017419A (en) * 2011-07-11 2013-01-31 Picaso Cosmetic Laboratory Ltd Method for producing acid mucopolysaccharide, culture medium for producing acid mucopolysaccharide, and acid mucopolysaccharide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010631A1 (en) 2008-07-25 2010-01-28 電気化学工業株式会社 Method for producing hyaluronic acid
CN102124120A (en) * 2008-07-25 2011-07-13 电气化学工业株式会社 Method for producing hyaluronic acid
US20110207178A1 (en) * 2008-07-25 2011-08-25 Masamichi Hashimoto Method for producing hyaluronic acid
US8927234B2 (en) * 2008-07-25 2015-01-06 Denki Kagaku Kogyo Kabushiki Kaisha Method for producing hyaluronic acid
JP2013017419A (en) * 2011-07-11 2013-01-31 Picaso Cosmetic Laboratory Ltd Method for producing acid mucopolysaccharide, culture medium for producing acid mucopolysaccharide, and acid mucopolysaccharide

Similar Documents

Publication Publication Date Title
JPH04158796A (en) Production of aqueous solution of sodium hyaluronate
JPH0956394A (en) Preparation of hyaluronic acid by fermentation using streptococcus
JP5356388B2 (en) Method for producing hyaluronic acid
JPS61202694A (en) Production of l-glutamine by fermentation method
JPH0670754A (en) Biotechnological preparation of pseudomonas aeruginosa and l-rhamnose and use thereof
JPS6377891A (en) Production of antibiotic a/16686 composite
DE68914236T2 (en) Process for the production of sodium hyaluronate by fermentation.
JPH02234689A (en) Production of hyaluronic acid
JPS6394988A (en) Production of hyaluronic acid
JPH11500609A (en) Klebsiella pneumoniae, subsp. Novel strain of Pneumoniae and method for producing polysaccharide containing L-fucose
GB1564020A (en) Method of producting a polysaccharide through fermentation and the product obtained thereby
JPS63123392A (en) Production of hyaluronic acid
JPH0746992A (en) Production of hyaluronic acid
DE2445581C3 (en) Process for the preparation of D-gluconic acid-dlactam
JPS63141594A (en) Production of hyaluronic acid
JPS62289198A (en) Novel process of producing hyaluronic acid
JPS6251999A (en) Production of hyaluronic acid
JP3973312B2 (en) Method for producing hyaluronic acid by fermentation
JP2009284826A (en) Method for producing hyaluronic acid
DE3719332C2 (en) Process for the preparation of L-isoleucine
JPH0630604B2 (en) Hyaluronic acid manufacturing method
JPS63129991A (en) Production of hyaluronic acid
JPS61239898A (en) Production of hyaluronic acid
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
RU2148648C1 (en) Method of heteropolysaccharide producing